Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of PARP11 mRNA | CTD | PMID:29704546 | 4,4'-sulfonyldiphenol | decreases methylation | EXP | | 6480464 | bisphenol S results in decreased methylation of PARP11 gene | CTD | PMID:31601247 | 6-propyl-2-thiouracil | decreases expression | ISO | Parp11 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of PARP11 mRNA | CTD | PMID:30047161 | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of PARP11 mRNA | CTD | PMID:32845096 | acrylamide | affects expression | ISO | Parp11 (Rattus norvegicus) | 6480464 | Acrylamide affects the expression of PARP11 mRNA | CTD | PMID:28959563 | amitrole | decreases expression | ISO | Parp11 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of PARP11 mRNA | CTD | PMID:30047161 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of PARP11 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of PARP11 mRNA | CTD | PMID:33212167 | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of PARP11 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of PARP11 gene | CTD | PMID:25304211 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of PARP11 promoter | CTD | PMID:27901495 | benzo[e]pyrene | decreases methylation | EXP | | 6480464 | benzo(e)pyrene results in decreased methylation of PARP11 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | ISO | Parp11 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of PARP11 mRNA | CTD | PMID:25181051 and PMID:30816183 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PARP11 mRNA | CTD | PMID:36232920 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of PARP11 mRNA | CTD | PMID:26079696 | carbon nanotube | increases expression | ISO | Parp11 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of PARP11 mRNA | CTD | PMID:25554681 | chlorpyrifos | decreases expression | ISO | Parp11 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of PARP11 mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Parp11 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PARP11 gene | CTD | PMID:20938992 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of PARP11 mRNA | CTD | PMID:27392435 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of PARP11 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of PARP11 mRNA | CTD | PMID:25562108 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PARP11 mRNA | CTD | PMID:27188386 | folic acid | multiple interactions | ISO | Parp11 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PARP11 gene | CTD | PMID:20938992 | L-methionine | multiple interactions | ISO | Parp11 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PARP11 gene | CTD | PMID:20938992 | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of PARP11 mRNA | CTD | PMID:28903495 | methapyrilene | decreases methylation | EXP | | 6480464 | Methapyrilene results in decreased methylation of PARP11 intron | CTD | PMID:30157460 | methimazole | decreases expression | ISO | Parp11 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of PARP11 mRNA | CTD | PMID:30047161 | methoxychlor | affects methylation | ISO | Parp11 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of PARP11 gene | CTD | PMID:35440735 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of PARP11 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of PARP11 mRNA | CTD | PMID:28001369 | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of PARP11 mRNA | CTD | PMID:24768652 and PMID:25583101 | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of PARP11 mRNA | CTD | PMID:32845096 | pentachlorophenol | increases expression | ISO | Parp11 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of PARP11 mRNA | CTD | PMID:23892564 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PARP11 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of PARP11 mRNA | CTD | PMID:25351596 | sodium arsenite | affects methylation | EXP | | 6480464 | sodium arsenite affects the methylation of PARP11 gene | CTD | PMID:28589171 | sodium arsenite | affects expression | EXP | | 6480464 | sodium arsenite affects the expression of PARP11 mRNA | CTD | PMID:34032870 | tremolite asbestos | decreases expression | ISO | Parp11 (Mus musculus) | 6480464 | tremolite results in decreased expression of PARP11 mRNA | CTD | PMID:29279043 | triptonide | decreases expression | ISO | Parp11 (Mus musculus) | 6480464 | triptonide results in decreased expression of PARP11 mRNA | CTD | PMID:33045310 | valproic acid | affects expression | ISO | Parp11 (Mus musculus) | 6480464 | Valproic Acid affects the expression of PARP11 mRNA | CTD | PMID:17963808 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of PARP11 gene | CTD | PMID:29154799 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of PARP11 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of PARP11 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PARP11 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of PARP11 mRNA | CTD | PMID:37505509 | |